Frontiers Case report: Short-term eculizumab use in atypical HUS
Por um escritor misterioso
Descrição
Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients - ScienceDirect
Frontiers Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
PDF] Atypical hemolytic uremic syndrome: a syndrome in need of clarity
PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome
Frontiers Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
PDF) Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing
Optimal management of atypical hemolytic uremic disease: challenges an
PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
Frontiers Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation
PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
PDF) Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
de
por adulto (o preço varia de acordo com o tamanho do grupo)
